Manipal Hospitals collaborates with DRL to include Sputnik V in its vaccine portfolio – ET HealthWorld

Bengaluru, 6th June 2021: Manipal Hospitals, India’s second largest multi-speciality hospital chain has been at the forefront of the vaccine drive in the country and aims to reach as many people as possible. Today, the hospital chain collaborates with Dr. Reddy’s Laboratories (”Dr. Reddy’s”) to add the Sputnik V vaccine pilot in its existing vaccine portfolio that comprises of Covishield and Covaxin. The roll out of the Sputnik V vaccine by Manipal Hospitals in Bengaluru is part of the limited pilot soft launch initiated by Dr. Reddy’s in Hyderabad last month.

Speaking about the new development, Mr Karthik Rajagopal, COO, Manipal Health Enterprises Pvt Ltd, “We are delighted to state that Manipal Hospitals is well prepared to roll out the Sputnik V vaccine pilot. Manipal Hospitals has worked closely with Dr. Reddy’s to create the state-of-the-art infrastructure to maintain Sputnik V vaccine. The hospital chain has successfully conducted vaccination drives with Covishield and Covaxin across the country till date and will continue the efforts along with the new addition of Sputnik V. We are expecting the vaccine to be available for the public soon in the latter half of the month.”

Addressing the need of the hour especially with the first batch of the Sputnik V vaccine directly transported from Russia, Manipal Hospitals has invested in creating a robust cold chain storage infrastructure as the vaccine needs to be stored in minus 18⁰ centigrade. Manipal Hospitals and Dr. Reddy’s took extensive efforts to ensure stringent cold chain maintenance as per the required guidelines for the vaccine. The cold chain storage even has a real-time logger which records the temperature every second.

M.V. Ramana, CEO – Branded Markets (India & Emerging Markets), Dr. Reddy’s, said: “We are pleased to collaborate with Manipal Hospital in Bengaluru as we scale up our soft pilot launch of the Sputnik V vaccine in India and extend it to more cities ahead of the commercial launch later in June. In the upcoming months we hope to inoculate as many Indians as possible.”